Peripheral artery disease in patients with stable coronary artery disease in general practice: results from an Italian nationwide study—PAD & CAD study
Marta Baviera,Andreana Foresta,Luisa Ojeda Fernandez,Ginevra Torrigiani,Mauro Tettamanti,Maria Carla Roncaglioni,Claudio Cimminiello,PAD, C. A. D. Study Group,Alberto Aronica,Valentina Cascini,Silvia Muggia,Alessandra Quaglini,Donatella Maria Rizzi,Marco Visconti,Aurora Habeeb Allah,Claudia Augurio,Sabrina Bonsangue,Pierclaudio Brasesco,Dino Bacca,Gemma Luisa Baldari,Valeria Maria Messina,Beatrice Musolino,Andrea Pedemonte,Luca Pestarino,Paolo Picco,Carlo Proietti,Giuseppe Fabio Stellini,Danilo Vicari,Antonio Calicchia,Daniela Antonucci,Antonio De Simone,Alessandra Innamorati,Quinto Campolo,Francesco Biasi,Carmelo Geremia,Carmela Mangiola,Giuseppe Marino,Antonino Musolino,Paolo Pensabene,Giuseppe Versaci,Stefania Laura Calvisi,Elisa Mela,Giuseppe Roscitano,Gianfabio Servidio,Mario D’Oria
DOI: https://doi.org/10.1007/s11739-024-03771-9
2024-10-01
Internal and Emergency Medicine
Abstract:Peripheral artery disease (PAD) remains underdiagnosed in patients with coronary artery disease (CAD) and barriers persist to measure screening PAD in routine clinical practice. We assessed the prevalence of PAD in patients with CAD in Italian primary care setting using an easy automatic instrument to measure ankle brachial pressure index (ABI). A multicenter, observational study was conducted with 32 General Practitioners (GPs). Prevalence of PAD was calculated dividing the number of patients with abnormal ABI value, or with symptoms associated with PAD or history of lower limb revascularization procedures, over the total number of patients included in the study. Incidence of major CV clinical events and all-cause death was also evaluated at 12 months in both CAD and CAD + PAD groups. In total, 713 CAD patients were included in the study, 148 (20.8%) patients had also PAD, asymptomatic in nearly 15% of them (106). The 35.4% of patients had ABI value ≤ 0.9 and 46.0% > 1.3 ABI. A significantly higher incidence of major CV events and all-cause death was seen in patients with PAD than in those without. Over 80% of patients received the therapy for secondary CV prevention and difference was seen between groups. Our findings showed that the use of an easy automatic instrument to measure ABI, easily managed by nurses, allowed to detect PAD in a relevant proportion of CAD patients who otherwise would not have been recognized. This encourages performing PAD screening in primary care setting to optimize the management of major CV risk factors associated with PAD. NCTumber: NCT03921905
medicine, general & internal